Moderna, Inc. (NASDAQ: MRNA) Investment Updates and Stock Performance
Moderna(US:MRNA) Financial Modeling Prep·2025-12-12 07:03Jefferies initiated coverage of Moderna, Inc. (NASDAQ: MRNA) with a "Hold" rating and a stock price of $29.62.Amundi reduced its stake in Moderna by 31.9%, selling 425,861 shares.Other investment firms, including Natixis Advisors LLC and Charles Schwab Investment Management Inc., have increased their holdings in Moderna.Moderna, Inc. (NASDAQ: MRNA) is a biotechnology company known for its work in developing mRNA-based vaccines and therapeutics. The company gained significant attention during the COVID-19 pa ...